Mast To Develop Vepoloxamer (MST-188) In Chronic Heart Failure

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/11/2026

1. SKHY
2. USO
3. SPY
4. META
5. DAL
6. PEP
7. SKHYV
8. ALP
9. GTM
10. NVDA

Go back to Mast To Develop Vepoloxamer (MST-188) In Chronic Heart Failure
MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 8.60 +0.11 (1.30%)
Previous Close $8.49    52 Week High $0.71 
Open $9.35    52 Week Low $0.07 
Day High $9.60    P/E N/A 
Day Low $8.36    EPS $-0.35 
Volume 7,189,906       

MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 8.60 +0.11 (1.30%)
Previous Close $8.49    52 Week High $0.71 
Open $9.35    52 Week Low $0.07 
Day High $9.60    P/E N/A 
Day Low $8.36    EPS $-0.35 
Volume 7,189,906